SBN sun biomedical limited

latest announcement, page-8

  1. 3,928 Posts.
    lightbulb Created with Sketch. 688
    One thing that concerns me is that the new executive directors haven't much skin in the game. I would think they'd buy on market. H Digby dropped $20k into Cynata late last year:

    http://www.asx.com.au/asxpdf/20131219/pdf/42lqbmq1jsgb2d.pdf

    IMO buying on-market SBN would make a hell of a difference, not because it would move the price but because it would assure shareholders that directors believe in the company.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.